Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension

International Journal of Cardiology

Volumn 135, Issue 1, 2009, Pages 21-26

  Lammers, Astrid E ^a   Hislop, Alison A ^b   Haworth, Sheila G ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

B type natriuretic peptide; Paediatrics; Prognosis; Pulmonary hypertension

Indexed keywords

BOSENTAN; BRAIN NATRIURETIC PEPTIDE; NITRIC OXIDE; PROSTACYCLIN; PROSTANOID; SILDENAFIL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART TRANSPLANTATION; HUMAN; IDIOPATHIC DISEASE; INFANT; LUNG ARTERY PRESSURE; LUNG DISEASE; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; ROC CURVE; SENSITIVITY ANALYSIS; VASCULAR RESISTANCE; WALKING;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; KAPLAN-MEIERS ESTIMATE; LUNG TRANSPLANTATION; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 67349165396     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.03.009     Document Type: Article

References (35)

1. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
2. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 9380 (2003) 316-322
3. Pruszczyk P. N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. J Card Fail 11 5 Suppl (2005) S65-69
4. Yoshimura M., Yasue H., Okumura K., Ogawa H., Jougasaki M., Mukoyama M., et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87 2 (1993) 464-469
5. Leuchte H.H., Holzapfel M., Baumgartner R.A., Neurohr C., Vogeser M., and Behr J. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 128 4 (2005) 2368-2374
6. Kazanegra R., Cheng V., Garcia A., Krishnaswamy P., Gardetto N., Clopton P., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7 1 (2001) 21-29
7. Richards A.M., Crozier I.G., Yandle T.G., Espiner E.A., Ikram H., and Nicholls M.G. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69 5 (1993) 414-417
8. Nagaya N., Nishikimi T., Okano Y., Uematsu M., Satoh T., Kyotani S., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 1 (1998) 202-208
9. Nagaya N., Nishikimi T., Uematsu M., Satoh T., Kyotani S., Sakamaki F., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 8 (2000) 865-870
10. Nir A., Bar-Oz B., Perles Z., Brooks R., Korach A., and Rein A.J. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 93 5 (2004) 603-607
11. Law Y.M., Keller B.B., Feingold B.M., and Boyle G.J. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95 4 (2005) 474-478
12. Cowley C.G., Bradley J.D., and Shaddy R.E. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25 4 (2004) 336-340
13. Koch A., Zink S., and Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 27 7 (2006) 861-866
14. Kurotobi S., Kawakami N., Shimizu K., Aoki H., Nasuno S., Takahashi K., et al. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26 4 (2005) 425-430
15. Westerlind A., Wahlander H., Lindstedt G., Lundberg P.A., and Holmgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93 3 (2004) 340-345
16. Mir T.S., Marohn S., Laer S., Eiselt M., Grollmus O., and Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110 6 (2002) e76
17. Weber M., and Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 92 6 (2006) 843-849
18. Luchner A., Hengstenberg C., Lowel H., Riegger G.A., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 1 (2005) 118-123
19. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 25 (2000) 3074-3079
20. Edwards B.S., Zimmerman R.S., Schwab T.R., Heublein D.M., and Burnett Jr. J.C. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 62 2 (1988) 191-195
21. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 1 (2002) 111-117
22. Bolger A.P., Sharma R., Li W., Leenarts M., Kalra P.R., Kemp M., et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106 1 (2002) 92-99
23. Micheletti A., Hislop A.A., Lammers A., Bonhoeffer P., Derrick G., Rees P., et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 92 7 (2006) 969-972
24. Yeo K.T., Wu A.H., Apple F.S., Kroll M.H., Christenson R.H., Lewandrowski K.B., et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338 1-2 (2003) 107-115
25. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 8 (2003) 875-878
26. Soldin S.J., Soldin O.P., Boyajian A.J., and Taskier M.S. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 366 1-2 (2006) 304-308
27. Leuchte H.H., Holzapfel M., Baumgartner R.A., Ding I., Neurohr C., Vogeser M., et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 43 5 (2004) 764-770
28. Hoeper M.M., Oudiz R.J., Peacock A., Tapson V.F., Haworth S.G., Frost A.E., et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43 12 Suppl S (2004) 48S-55S
29. Fijalkowska A., Kurzyna M., Torbicki A., Szewczyk G., Florczyk M., Pruszczyk P., et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129 5 (2006) 1313-1321
30. Cohen S., Springer C., Avital A., Perles Z., Rein A.J., Argaman Z., et al. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?. Pediatrics 115 5 (2005) 1347-1350
31. Lin N.C., Landt M.L., Trinkaus K.M., Balzer D.T., Kort H.W., and Canter C.E. Relation of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients < 20 years of age with heart disease. Am J Cardiol 96 6 (2005) 847-850
32. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36 5 (2000) 1587-1593
33. Tamura N., Ogawa Y., Chusho H., Nakamura K., Nakao K., Suda M., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 97 8 (2000) 4239-4244
34. Cargill R.I., and Lipworth B.J. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans. Br J Clin Pharmacol 40 6 (1995) 585-590
35. Richards A.M., Crozier I.G., Holmes S.J., Espiner E.A., Yandle T.G., and Frampton C. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens 11 2 (1993) 163-170